EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

A 3D Bioprinted Platform That Maintains the Functional Integrity of Primary AML Cells

Wanling Huang, Bo Deng iD, Nini Guo, Yiyi Ding, Zhangjingwen Xu, Yiwen Lu, Yue Ma, Qian Ren, Nan Wang iD, Pengyu Huang, Xiaotong Ma iD

Cell Proliferation · 2026-11 · 59 (11)

DOI: 10.1111/cpr.70250 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cell Proliferation, online erschienen am 16.06.2026. Verfasst von Wanling Huang und 10 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Institute of Hematology & Blood Diseases Hospi…. Hauptthemen laut MEDLINE: Leukemia, Myeloid, Acute, Printing, Three-Dimensional, Bioprinting. Die Arbeit nennt 51 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Key R&D Program of China, CAMS Innovation Fund for Medical Sciences, The Fundamental Research Funds for Central Universities, Peking Union Medical College.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Acute myeloid leukaemia (AML) urgently requires more reliable in vitro platforms for drug evaluation, as existing models often fail to maintain the phenotypic, metabolic, and pharmacologic features of primary leukaemic cells. To address this limitation, we developed a rapidly assembled, screening‐compatible three‐dimensional (3D) bioprinting platform. It encapsulates patient‐derived bone marrow mononuclear cells within a gelatin‐hyaluronic acid hydrogel, whose mechanical properties are tuned to match those of native bone marrow. Within this controlled 3D microenvironment, primary AML cells better maintain an in vivo‐like state, showing enhanced viability, sustained proliferative capacity, preservation of stem‐like subpopulations, and drug responses that more closely mirror clinical behaviour. Transcriptomic profiling further revealed robust activation of MYC target programs and mTORC1 signalling, accompanied by elevated oxidative phosphorylation and glycolytic activity, indicative of the highly proliferative and metabolically active state exhibited by AML cells in vivo. These findings demonstrate that our patient‐specific, 3D bioprinted system provides a high‐fidelity model. This model faithfully recapitulates AML physiology and metabolic features while capturing inter‐patient variability. Consequently, it offers a more reliable and predictive platform for preclinical drug assessment.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Leukemia, Myeloid, AcutePrinting, Three-DimensionalBioprintingHumansCell ProliferationHydrogelsAnimalsCell SurvivalHyaluronic AcidMechanistic Target of Rapamycin Complex 1Gelatin

Stichwörter der Autor:innen

3D bioprintingacute myeloid leukaemiadrug screeningmetabolism

Substanzen

HydrogelsHyaluronic AcidMechanistic Target of Rapamycin Complex 1Gelatin

Autor:innen und Institutionen

  • State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical Colleg…
  • Tianjin Institutes of Health Science, Tianjin, China.
  • State Key Laboratory of Advanced Medical Materials and Devices, Engineering Research Center of Pulmonary and Critical Care Medicine Technology and Device (Ministry of Education), Tianjin Key Laboratory of Biomedical Mat…

ORCID-Profile: Bo Deng, Nan Wang, Xiaotong Ma

Förderung

  • National Key R&D Program of China
  • CAMS Innovation Fund for Medical Sciences
  • The Fundamental Research Funds for Central Universities, Peking Union Medical College
  • National Natural Science Foundation of China
  • The Non-profit Central Research Institute Fund of Chinese Academy of Medical Sciences
  • National Key Research and Development Program of China

Zitieren

APA

Huang, W., Deng, B., Guo, N., Ding, Y., Xu, Z., Lu, Y., Ma, Y., Ren, Q., Wang, N., Huang, P., & Ma, X. (2026). A 3D Bioprinted Platform That Maintains the Functional Integrity of Primary AML Cells. Cell Proliferation, 59(11). https://doi.org/10.1111/cpr.70250

Vancouver

Huang W, Deng B, Guo N, Ding Y, Xu Z, Lu Y, et al. A 3D Bioprinted Platform That Maintains the Functional Integrity of Primary AML Cells. Cell Proliferation. 2026;59(11). doi:10.1111/cpr.70250

BibTeX
@article{Huang2026,
  author = {Huang, Wanling and Deng, Bo and Guo, Nini and Ding, Yiyi and Xu, Zhangjingwen and Lu, Yiwen and Ma, Yue and Ren, Qian and Wang, Nan and Huang, Pengyu and Ma, Xiaotong},
  title = {A 3D Bioprinted Platform That Maintains the Functional Integrity of Primary AML Cells},
  journal = {Cell Proliferation},
  year = {2026},
  volume = {59},
  number = {11},
  doi = {10.1111/cpr.70250}
}
Kostenlos starten →